Company
2020 GenoSystems
AI-Powered Blood Tests for the Prevention & Early Detection of Cancers & Chronic Diseases
Also known as 20/20 BioLabs
- Status
- Operatingas of 2026-09-20
- Business model
- B2B2C
- Customers
- individuals and providers
Claim, correct or request removal
Record updated 20 September 2026
About
20/20 BioLabs develops and commercializes cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our advanced diagnostics leverage machine learning algorithms built on extensive real-world data, offering exceptional accuracy and convenience for individuals and providers.
Products
- Other
- OneTest for Cancer
- Other
- OneTest for Longevity
Loading relationship preview